MuRF-1/Trim63 and Atrogin1/Fbxo32 are well-known E3 ligases that are upregulated in conditions that lead to muscle wasting, such as those seen in chemotherapy, cancer cachexia, glucocorticoid treatment, and muscle disuse (9, 31). Here, FBXO32 is linked to cancer.